You are here » Home » Companies » Company Overview » Beta Drugs Ltd

Beta Drugs Ltd.

BSE: 535022 Sector: Health care
NSE: BETA ISIN Code: INE351Y01019
BSE 05:30 | 01 Jan Beta Drugs Ltd
NSE 00:00 | 07 May 208.45 9.90
(4.99%)
OPEN

208.40

HIGH

208.45

LOW

208.40

OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty

Beta Drugs Ltd. (BETA) - Company History

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21 2005. Subsequently the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985 by its promoter Vijay Batra who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra took over the company from Kiran Goyal Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Company's products range from anti-cancer tablets capsules injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31 2017 the company had a portfolio of over 50 products catering to various oncology diseases including breast brain bone lung mouth head & neck prostate haematology cervics oeaophagus etc.

.